HTGF, Think.Health Ventures and Business Angels have also supplied funding to Max Planck Institute for Biochemistry mass spectrometry spinout PreOmics.

PreOmics, a Germany-based mass spectrometry sampling technology business based on research from Max Planck Institute for Biochemistry, has obtained €3.3m ($3.8m) in a series A round backed by public-private partnership High-Tech Gründerfonds. The round was led by Think.Health Ventures with participation from syndicate Business Angels. Founded in 2016, PreOmics has devised a technology that helps…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.